Moderna Inc (MRNA)

333.61
-1.23(-0.37%)
After Hours
334.00
+0.39(+0.12%)
- Real-time Data
  • Volume:
    8,515,186
  • Bid/Ask:
    333.48/334.24
  • Day's Range:
    331.01 - 347.87

MRNA Overview

Prev. Close
334.84
Day's Range
331.01-347.87
Revenue
7.02B
Open
339.11
52 wk Range
65.5-496.71
EPS
8.01
Volume
8,515,186
Market Cap
135.16B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
18,843,226
P/E Ratio
41.80
Beta
-
1-Year Change
352.85%
Shares Outstanding
403,646,312
Next Earnings Date
04 Nov 2021
What is your sentiment on Moderna Inc?
or
Market is currently closed. Voting is open during market hours.

Moderna Inc News

Moderna Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyBuyBuy
Technical IndicatorsStrong BuyStrong SellNeutralSellStrong Buy
SummaryStrong BuyNeutralNeutralNeutralStrong Buy

Moderna Inc Company Profile

Moderna Inc Company Profile

Employees
1300

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmacéuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Read More
  • Can anyone advice, still good to buy or should sell?
    1
    • Best time to buy was last year.
      1
    • PE ratio below others with higher revenues which is great. I think the concern is declinig revenues.
      0
    • i advise is to sell and wait and watch. it should touch usd. 150 or probably lower. Parker
      1
  • Keep shorting. More competitors like MRK are entering covid vaccine/therapy space.
    1
    • Incredible it falling down to 300 or 200
      0
      • Yes,this is incredible
        0
    • Impossible stock falling!
      1
      • incredible
        0
    • Do it will be down to 200 ?
      0
      • Most probably
        0
    • Doooooown
      0
      • why we goes down?
        1
        • going 5% down sell on
          0
          • will close in green
            1
            • gentlemen good morning, as usual, I extend the invitation to anyone who is intrigued or interested in meeting new companies. In that case, so as not to bother the modernists of this forum further, switch over to Verrica Pharmaceuticals. Good gain to all. Ibanez.
              0
              • go faster bi10ch
                0
                • Beast mode
                  0
                  • price dropped by $20 in 40 minutes, ******* must have been the Japanese suspension of their vaccines over alleged 'metallic' particles in it. Although, this might actually be a good time to buy now that it's tanking because I seriously doubt the Japanese suspension will affect it in the long run. Positive outcomes for MRNA in the future, I can see it
                    0
                    • BS
                      0
                      • let's rise mrna, don't fall and rise the price again
                        4
                        • let's rise moderna, don't fall and rise the price again
                          1
                          • making profit. invest in novavax
                            2
                            • it may go down below 350. don't buy @ this lavel
                              2
                              • hopefully will go up
                                5
                                • Correction as expected
                                  1
                                  • Parabolic. Correction soon
                                    4
                                    • Anyone know why its dropping rapidly, despite recommendations to buy?
                                      0
                                      • i stand to coreect.. maybe in 15 days
                                        1
                                        • moderna to be a 1000 dollar company soon .. probably in next 3 months..
                                          9
                                          • probably...
                                            0
                                          • i stand to correct.. maybe in 1 5 days
                                            1
                                        • Hello, today the whole world is talking about the Moderna vaccine and the extension to other age groups
                                          0
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.